QT Vascular said today that the FDA approved the company’s request to expand an on-going pivotal study of its Chocolate Touch drug-coated balloon to include the use of atherectomy for lesion preparation.
The U.S. regulatory agency also approved the addition of subgroup analysis related to the use of atherectomy.
Get the full story at our sister site, Drug Delivery Business News.
The post QT Vascular expands pivotal trial of Chocolate Touch DCB appeared first on MassDevice.
from MassDevice http://bit.ly/2AQHfse
Cap comentari:
Publica un comentari a l'entrada